When Harsh Medicare Cuts Are Cause for Celebration

The Medicare cuts were big, but not as big as the market had feared, which is cause for celebration for Myriad.

Dave Williamson
Dave Williamson
Apr 2, 2014 at 7:53PM
Health Care

Another of today's winners in the health-care space is Myriad Genetics (NASDAQ:MYGN), up 11% today after Medicare reimbursement cuts were announced. Though the cuts were harsh, they were lower than the market had been fearing, and Myriad came out on top as a result.

In this video, Motley Fool health-care analyst David Williamson discusses the Medicare cuts and the fact that they were still extremely severe, despite not being as severe as once feared. He also gives investors a few reasons not to love Myriad Genetics, despite the boost it got today from the market's expectations game.